EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Broad spectrum SARS‐CoV ‐2‐specific immunity in hospitalized First Nations peoples recovering from COVID ‐19

Wuji Zhang iD, E Bridie Clemens, Lukasz Kedzierski, Brendon Y Chua, Mark Mayo, Claire Lonzi, Alexandra Hinchcliff, Vanessa Rigas, Bianca F Middleton, Paula Binks iD, Louise C Rowntree, Lilith F Allen und 13 weitere

Immunology & Cell Biology · 2023-11 · 101 (10) · 964-974

DOI: 10.1111/imcb.12691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology & Cell Biology, online erschienen am 19.09.2023. Verfasst von Wuji Zhang und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Austra…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indigenous peoples globally are at increased risk of COVID‐19‐associated morbidity and mortality. However, data that describe immune responses to SARS‐CoV‐2 infection in Indigenous populations are lacking. We evaluated immune responses in Australian First Nations peoples hospitalized with COVID‐19. Our work comprehensively mapped out inflammatory, humoral and adaptive immune responses following SARS‐CoV‐2 infection. Patients were recruited early following the lifting of strict public health measures in the Northern Territory, Australia, between November 2021 and May 2022. Australian First Nations peoples recovering from COVID‐19 showed increased levels of MCP‐1 and IL‐8 cytokines, IgG‐antibodies against Delta‐RBD and memory SARS‐CoV‐2‐specific T cell responses prior to hospital discharge in comparison with hospital admission, with resolution of hyperactivated HLA‐DR + CD38 + T cells. SARS‐CoV‐2 infection elicited coordinated ASC, Tfh and CD8 + T cell responses in concert with CD4 + T cell responses. Delta and Omicron RBD‐IgG, as well as Ancestral N‐IgG antibodies, strongly correlated with Ancestral RBD‐IgG antibodies and Spike‐specific memory B cells. We provide evidence of broad and robust immune responses following SARS‐CoV‐2 infection in Indigenous peoples, resembling those of non‐Indigenous COVID‐19 hospitalized patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAustraliaImmunoglobulin GIndigenous PeoplesImmunityAntibodies, Viral

Stichwörter der Autor:innen

Australian First Nations peoplesCOVID-19RBD and N antibodiesSARS-CoV-2-specific T cells

Substanzen

Immunoglobulin GAntibodies, Viral

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC, Australia.
  • Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Melbourne, VIC, Australia.
  • Menzies School of Health Research, Darwin, NT, Australia.
  • Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
  • ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.

ORCID-Profile: Wuji Zhang, Paula Binks, Jan Petersen, Stephen J Kent, Thi Ho Nguyen, Katherine Kedzierska

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Health and Medical Research Council
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Zhang, W., Clemens, E. B., Kedzierski, L., Chua, B. Y., Mayo, M., Lonzi, C., Hinchcliff, A., Rigas, V., Middleton, B. F., Binks, P., Rowntree, L. C., Allen, L. F., Tan, H. X., Petersen, J., Chaurasia, P., Krammer, F., Wheatley, A. K., Kent, S. J., Rossjohn, J., …, & Kedzierska, K. (2023). Broad spectrum SARS‐CoV ‐2‐specific immunity in hospitalized First Nations peoples recovering from COVID ‐19. Immunology & Cell Biology, 101(10), 964-974. https://doi.org/10.1111/imcb.12691

Vancouver

Zhang W, Clemens EB, Kedzierski L, Chua BY, Mayo M, Lonzi C, et al. Broad spectrum SARS‐CoV ‐2‐specific immunity in hospitalized First Nations peoples recovering from COVID ‐19. Immunology & Cell Biology. 2023;101(10):964-974. doi:10.1111/imcb.12691

BibTeX
@article{Zhang2023,
  author = {Zhang, Wuji and Clemens, E Bridie and Kedzierski, Lukasz and Chua, Brendon Y and Mayo, Mark and Lonzi, Claire and Hinchcliff, Alexandra and Rigas, Vanessa and Middleton, Bianca F and Binks, Paula and Rowntree, Louise C and Allen, Lilith F and Tan, Hyon-Xhi and Petersen, Jan and Chaurasia, Priyanka and Krammer, Florian and Wheatley, Adam K and Kent, Stephen J and Rossjohn, Jamie and Miller, Adrian and Lynar, Sarah and Nelson, Jane and Nguyen, Thi Ho and Davies, Jane and Kedzierska, Katherine},
  title = {Broad spectrum SARS‐CoV ‐2‐specific immunity in hospitalized First Nations peoples recovering from COVID ‐19},
  journal = {Immunology & Cell Biology},
  year = {2023},
  volume = {101},
  number = {10},
  pages = {964--974},
  doi = {10.1111/imcb.12691}
}
Kostenlos starten →